Supported by

TAVI (Transcatheter aortic valve implantation)

Latest TAVI content in interventional cardiology - research, practice, and education

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1364 results

Reducing permanent pacemaker implantation for TAVI: techniques to optimise patient outcomes

17 May 2022 – From EuroPCR 2022

Lars Søndergaard, Won-Keun Kim, and Christophe Saint Etienne came together for EuroPCR 2022 to share their experience of implanters achieving single-digit permanent pacemaker implantation: learn about the latest technique and new product features to reduce permanent pacemaker implantation.

View more videos and course resources here!

Reducing permanent pacemaker implantation for TAVI: techniques to optimise patient outcomes

Worldwide experiences on contemporary TAVI implantation technique with Evolut platform

17 May 2022 – From EuroPCR 2022

Through this discussion between Yohei Ohno, Kendra Grubb, and Stefan James recorded for EuroPCR 2022, discover recent updates on the COT experience/studies (optimize PRO 400pts, OCEAN TAVI, personal experience), find out about key success factors/steps on the technique to achieve optimal results, and learn how to...

Worldwide experiences on contemporary TAVI implantation technique with Evolut platform

How to manage patients with coronary artery disease and aortic stenosis? The PRIME CLASS study

17 May 2022 – From EuroPCR 2022

Thanks to this interview between Enrique Gutierrez Ibanez and Nicolas Meneveau shot for EuroPCR 2022, be aware of the clinical evidence and the studies currently ongoing for the “coronary artery disease and aortic stenosis” clinical setting, learn more about the current approach to diagnose and treat...

How to manage patients with coronary artery disease and aortic stenosis? The PRIME CLASS study

Hemodynamics and minimalist TAVI - how does it fit?

17 May 2022 – From EuroPCR 2022

Watch this presentation by Thomas Modine for EuroPCR 2022 to hear about the multimodality approach to optimise TAVI procedure and its impact on post-operative course, to get an update on how minimalist TAVI can be performed successfully in most patients without conversion to general anaesthesia, and...

Hemodynamics and minimalist TAVI - how does it fit?

DurAVR THV: a valve designed for life

17 May 2022 – From EuroPCR 2022

Watch this discussion between Christopher Meduri and Vinayak Bapat to understand the features of the DurAVR THV, a transcatheter aortic valve designed to last longer and work better for lifetime management of aortic stenosis patients due to its unique leaflet design that shows clear haemodynamic advantages...

DurAVR THV: a valve designed for life

CoreValve™ and Evolut™ TAVI systems

13 May 2022

Sponsored by Medtronic

CoreValveTM and EvolutTM TAVI systems, the best TAVI vs SAVR durability data yet

CHOICE CLOSURE - Proven benefits from a randomised trial of suture-based closure device strategy for transfemoral transcatheter aortic valve replacement

17 May 2022 – From EuroPCR 2022

Watch this presentation of the CHOICE CLOSURE trial proposed by Mohamed Abdel-Wahab for EuroPCR 2022 to understand the benefits of suture-based strategy in terms of access-site or access-related major and minor vascular complications, to compare suture-based to plug-based closure in large-bore arterial access, and to analyze...

CHOICE CLOSURE - Proven benefits from a randomised trial of suture-based closure device strategy for transfemoral transcatheter aortic valve replacement

Transcaval versus transaxillary TAVR in contemporary practice - a propensity-weighted analysis

09 May 2022

As there has been no systematic comparison of transcaval and transaxillary access so far, the present study aimed to compare these two approaches with each other, as well as with transfemoral access.

Jonathan Curio

Reviewer

Jonathan Curio

Reviewer

Salvatore Brugaletta
Transcaval versus transaxillary TAVR in contemporary practice - a propensity-weighted analysis

A case of severe aortic stenosis and severe calcified ostial RCA disease

01 Jun 2022

Techniques to manage simultaneously severe calcified aortic stenosis and severe heavily calcified ostial RCA disease combining TAVI and ROTABLATION.

Petros Dardas

Author

Petros Dardas
Nikolaos Mezilis

Author

Nikolaos Mezilis
A case of severe aortic stenosis and severe calcified ostial RCA disease

Crash TAVI-in-TAVI complicated by coronary obstruction

20 Apr 2022

Thanks to this Image in Interventional Cardiology, view an emergency TAVI-in-TAVI for cardiogenic shock secondary to acute valve degeneration complicated by left main stem obstruction treated successfully by chimney stenting.

Crash TAVI-in-TAVI complicated by coronary obstruction

Insights from the Corevalve US Pivotal and SURTAVI trials

05 Apr 2022

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Pierre Deharo

Author

Pierre Deharo
Giuseppe Di Gioia

Author

Giuseppe Di Gioia
Insights From the Corevalve US Pivotal and SURTAVI Trials

Restriction in supra-annular transcatheter heart valve leaflet mobility during coronary access after valve-in-valve TAVI

05 Apr 2022

This Image in Interventional Cardiology highlights how patient-specific ex vivo simulations offer physicians the opportunity to observe and evaluate the potential in vivo impact of different techniques particularly for complex structural heart interventions.

Restriction in supra-annular transcatheter heart valve leaflet mobility during coronary access after valve-in-valve TAVI

No go (again) for oral anticoagulation after TAVR: Results of the ADAPT-TAVR trial

04 Apr 2022

Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.

Francesco Costa

Author

Francesco Costa
A Randomized ADAPT-TAVR Trial: Edoxaban Vs DAPT For Valve Thrombosis and Cerebral Thromboembolism After TAVR

PCRonline @ ACC 2022 Scientific Sessions

29 Mar 2022

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.

PCRonline @ ACC.22 Scientific Sessions

How should I treat? - TAVI in bicuspid aortic valve stenosis: tips and tricks for an optimal result

06 Apr 2022

A 70-year-old male patient was referred to hospital with signs of acute myocardial infarction. Echocardiography confirmed impaired left ventricular function and severe low flow, low gradient aortic valve stenosis. Would you go for surgical aortic valve replacement or transfemoral TAVI?

Author

Joerg Kempfert
Christoph Klein

Author

Christoph Klein
Marian Kukucka

Author

Marian Kukucka
Karel Van Praet

Author

Karel Van Praet
Axel Unbehaun

Author

Axel Unbehaun
TAVI in bicuspid aortic valve stenosis: tips and tricks for an optimal result

How should I treat? - How to reduce cardiac conduction disturbance with Sapien 3 valve?

16 Mar 2022

Conduction disturbances remain the most common complications of TAVI and its main drawback compared to surgery. How would you treat this 82-year-old man, height 1.68 m, weight 112 kg, with peripheral artery disease, who presented with severe aortic stenosis and symptoms of NYHA Class 3 breathlessness?

Oualid Zouaghi

Author

Oualid Zouaghi
How should I treat? - How to reduce cardiac conduction disturbance with Sapien 3 valve?

Cusp overlay implantation technique – planning step-by-step

11 Feb 2022

The cusp-overlay method aims to implant the self-expandable device higher than in former ways without device pop-out upon release and it reduces pacemaker rates significantly. 

Philipp Lauten

Author

Philipp Lauten
Cusp overlay implantation technique

#5 - How should I optimise my TAVI patients journey?

27 Jan 2022

View the replay of this PCR Webinar on TAVI with S. Toggweiler, D. Blackman and N. Van Mieghem

#5 - How should I optimise my TAVI patients journey?

#4 - How should I manage complex anatomical situations during my TAVI procedures?

27 Jan 2022

Watch the replay of this PCR Webinar on TAVI with O.D. Backer, M. Abdel-Wahab and D. Tchétché

#4 - How should I manage complex anatomical situations during my TAVI procedures?

Cusp symmetry and coronary ostial eccentricity and its impact on coronary access following TAVR

26 Jan 2022

Recently, coronary access has been recognized as an important consideration in the lifetime management of patients with severe aortic stenosis...

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Cusp symmetry and coronary ostial eccentricity and its impact on coronary access following TAVR